High-density lipoprotein size distribution can differ between subjects with alcoholic and non-alcoholic fatty liver disease

Clinical Laboratory

Volumn 60, Issue 2, 2014, Pages 319-322

  Tsuzaki, Kokoro ^a   Kotani, Kazuhiko ^a,b   Fujiwara, Shinji ^c   Sano, Yoshiko ^a   Sakane, Naoki ^a  

^a NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c Mima City National Health Insurance Koyadaira Clinic   (Japan)

Author keywords

Alcohol; Cardiovascular disease; High density lipoprotein

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN;

ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOLIC FATTY LIVER; ARTICLE; CHEMOLUMINESCENCE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ELECTROPHORETIC MOBILITY; ENZYME IMMUNOASSAY; FUNCTION TEST KIT; HUMAN; IMMUNOLOGY TEST KIT; LABORATORY TEST; LIPOPROTEIN BLOOD LEVEL; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; PREDICTIVE VALUE; PROTEIN ANALYSIS; RISK FACTOR; SERUM;

AGED; FATTY LIVER; FATTY LIVER, ALCOHOLIC; HUMANS; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; MOLECULAR WEIGHT;

EID: 84895791558     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2013.130228     Document Type: Article

References (16)

1. Nagata K, Suzuki H, Sakaguchi S. Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis. J Toxicol Sci 2007;32:453-68.
2. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003;37:1202-19. (Pubitemid 36538699)
3. Bataller R, Rombouts K, Altamirano J, et al. Fibrosis in alcoholic and nonalcoholic steatohepatitis. Best Pract Res Clin Gastroenterol 2011;25:231-44.
4. Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001;50:1844-50. (Pubitemid 33641605)
5. Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003;37:917-23. (Pubitemid 36397405)
6. Tian L, Long S, Li C, et al. High-density lipoprotein subclass and particle size in coronary heart disease patients with or without diabetes. Lipids Health Dis 2012;11:54.
7. Pascot A, Lemieux I, Prud'homme D, et al. Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity. J lipid Res 2001;42:2007-14. (Pubitemid 34001049)
8. Lamon-Fava S, Herrington DM, Reboussin DM, et al. Plasma levels of HDL subpopulations and remnant lipoproteins predict the extent of angiographically-defined coronary artery disease in postmenopausal women. Arterioscler Thromb Vasc Biol 2008;28:575-9.
9. Griffith C, Bogart D. Alcohol consumption: can we safely toast to our health? Mo Med 2012:109;459-65.
10. Haffner SM, Applebaum-Bowden D, Wahl PW, et al. Epidemiological correlates of high density lipoprotein subfractions, apolipoproteins A-I, A-II, and D, and lecithin cholesterol acyltransferase. Effects of smoking, alcohol, and adiposity. Arteriosclerosis 1985;5:169-77. (Pubitemid 15145373)
11. Sillanaukee P, Koivula T, Jokela H, et al. Relationship of alcohol consumption to changes in HDL-subfractions. Eur J Clin Invest 1993;23:486-91. (Pubitemid 23243940)
12. Kalogirou M, Tsimihodimos V, Gazi I, et al. Effect of ezetimibe monotherapy on the concentration of lipoprotein subfractions in patients with primary dyslipidaemia. Curr Med Res Opin 2007;23:1169-76. (Pubitemid 46799601)
13. Szczepaniak LS, Nurenberg P, Leonard D, et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 2005;288:E462-8. (Pubitemid 40110657)
14. Reaven GM, Chen YD, Jeppesen J, et al. Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. J Clin Invest 1993;92:141-6. (Pubitemid 23208989)
15. van der Gaag MS, van Tol A, Vermunt SH, et al. Alcohol consumption stimulates early steps in reverse cholesterol transport. J Lipid Res 2001;42,:2077-83. (Pubitemid 34001057)
16. Hannuksela ML, Rämet ME, Nissinen AE, et al. Effects of ethanol on lipids and atherosclerosis. Pathophysiology 2004;10:93-103. (Pubitemid 38296774)